Articulation disorder

Summary

Articulation disorder (MONDO:0002903) is a disease and 7 clinical trials. A subtype of speech disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 7

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	articulation disorder
Mondo ID	MONDO:0002903
MeSH	D001184
DOID	DOID:4186
NCIT	C92564
SNOMED CT	386701004
UMLS	C0003910
MedGen	2081
Is cancer (heuristic)	no

Also known as: phonological disorder

Disease family

This is a subtype of speech disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › mental disorder › developmental disorder of mental health › specific developmental disorder › communication disorder › speech disorder › articulation disorder

Related subtypes (3): stutter disorder, echolalia, mutism

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 7.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	7

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07016243	Not specified	RECRUITING	Correlation Between Deficits in Knee ROM Recovery and Difficulty in Dorsiflexing the Tibio-tarsal Joint in Patients Undergoing Total Knee Replacement Surgery.
NCT07613268	Not specified	NOT_YET_RECRUITING	Exploratory Trial of the HiDongDong Language Rehabilitation App for Articulation Delay.
NCT02011243	Not specified	COMPLETED	Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players
NCT02705326	Not specified	COMPLETED	Evaluating the Efficacy of Opti-Speech for Speech Treatment
NCT03663972	Not specified	COMPLETED	Age-related Correlates of Treatment for Late-acquired Sounds
NCT04392817	Not specified	COMPLETED	Efficacy of an Arabic Articulatory Error Remediation Software Program in Patients With Velopharyngeal Valve Dysfunction:
NCT06322472	Not specified	COMPLETED	The Relationship Between Phonological Awareness Skills And Home Environment Literacy in Cochlear Implant Users